Crossover Medical
Malvern, US · Founded 2026 · Delaware corporation
Crossover is a stealth-mode medical device company developing two Class II (510(k) pathway) implant systems for ankle fracture fixation, specifically fibular nailing and syndesmosis repair. It targets the US lower-extremity trauma fixation market and is building the devices with an acquisition-oriented strategy for strategic orthopedic partners and surgeon advisors.
Founders & leadership
JF
Jeffrey F. O'Donnell, Sr.Executive
JO
Jeff O'Donnell Jr.Chief Executive Officer
BR
Bill RhodaChief Technology Officer
Board
HT
Harry Thomas Hall, IVBoard director
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2026
▶$500KraisedFeb 2026 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedFeb 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Harry Thomas Hall, IVDirector
- William Scott RhodaExecutive Officer, Director
- Jeffrey O'Donnell, Jr.Executive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- Proceeds to insiders
- $200K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Crossover Medical do?
- Crossover is a stealth-mode medical device company developing two Class II (510(k) pathway) implant systems for ankle fracture fixation, specifically fibular nailing and syndesmosis repair. It targets the US lower-extremity trauma fixation market and is building the devices with an acquisition-oriented strategy for strategic orthopedic partners and surgeon advisors.
- How much funding has Crossover Medical raised?
- Crossover Medical has disclosed $500K raised across 1 round.
- Where is Crossover Medical headquartered?
- Crossover Medical is headquartered in Malvern, US.